EXECUTIVE ENGAGEMENTS
POOL
2193
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
393
Interactions with Platform & by Email
PARTICIPANTS
66
Unique # Participated
VALIDATIONS
22
Responses Validated*
COMPANIES
38
Responses Validated*
* Login for a full stack data experience
DATE
MAY 2021
TABLES
125
PAGES
150
EDITION
8
PRICE
USD 4950
CODE
MCP10010
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for 3D Cell Culture estimated at US$972.1 Million in the year 2020, is projected to reach a revised size of US$2.4 Billion by 2027, growing at a CAGR of 13.7% over the analysis period 2020-2027.Scaffold-based, one of the segments analyzed in the report, is projected to grow at a 13.9% CAGR to reach US$1.1 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Scaffold-free segment is readjusted to a revised 13.1% CAGR for the next 7-year period. This segment currently accounts for a 27.2% share of the global 3D Cell Culture market.
The 3D Cell Culture market in the U.S. is estimated at US$341.2 Million in the year 2020. The country currently accounts for a 35.1% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$161.4 Million in the year 2027 trailing a CAGR of 14.8% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.3% and 11.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 16.3% CAGR while Rest of European market (as defined in the study) will reach US$161.4 Million by the year 2027.
In the global Microfluidics-based segment, USA, Canada, Japan, China and Europe will drive the 15.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$139.1 Million in the year 2020 will reach a projected size of US$377.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$186.4 Million by the year 2027.
SELECT PLAYERS
3D Biotek, LLC; Advanced Biomatrix, Inc.; Becton Dickinson and Company; Corning Inc.; Greiner Bio One International GmbH; Hamilton Company; InSphero AG; Lonza Group AG; Merck KGaA; Mimetas B.V.; Nanofiber Solutions; REPROCELL USA Inc.; Synthecon, Incorporated; Tecan Trading AG; Thermo Fisher Scientific Inc.
SEGMENTS
» Product (Scaffold-based, Scaffold-free, Microfluidics-based, Magnetic & Bioprinted) » Application (Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing, Tissue Engineering & Regenerative Medicine)
GEOGRAPHIES
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 3D Cell Culture Transforms Life Sciences Industry |
| 3D Cell Culture: An Introduction |
| 3D-Cell Culture Models |
| Benefits of 3D Cell Culture |
| Key 3D Cell Culture Formats |
| 3D Cell Culture—Different Techniques |
| Scaffold-Based 3D Cell Culture |
| Polymeric Hard Scaffolds |
| Biological Scaffolds |
| Micropatterned Surface Microplates |
| Non-Scaffold Based 3D Cell Culture |
| Hanging Drop Microplates |
| Spheroid Microplates with Ultra-Low Attachment (ULA) coating |
| Microfluidic 3D Cell Culture |
| Expanding Applications Fuel Growth in the Global 3D Cell Culture Market |
| Developed Regions Lead the 3D Cell Culture Market, Asia-Pacific to Register Faster Growth |
| Scaffold-based 3D Cell Culture Products Dominate the Market |
| Cancer and Stem Cell Research Leads the Global Market |
| Competitive Scenario |
| Key Commercial 3D Cell Culture Devices |
| 2. FOCUS ON SELECT PLAYERS |
| Recent Market Activity |
| 3. MARKET TRENDS & DRIVERS |
| Rising Incidence of Cancer Drives the Demand for 3D Cell Culture |
| EXHIBIT 1: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040 |
| EXHIBIT 2: Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018 |
| EXHIBIT 3: Number of New Cancer Cases and Deaths (in Million) by Region for 2018 |
| Increasing Demand for 3D Cell Culture in Drug Discovery |
| Use of 3D Cell Culture for Regenerative Medicine |
| Organoids as Alternatives to Using Animals in Experiments |
| Use of 3D Cell Culture for Regenerative Medicine |
| Microfluidic Chips Hold Potential in Addressing 3D Cell Culture Challenges |
| Technological Advancements Promote 3D Cell Culture Market |
| Researchers Use Lab-on-a-CD Technology to Generate Spheroid 3D Cell Cultures |
| 3D Bioprinting Holds Potential to Revolutionize Organ Transplantation Space |
| A Review of Research Efforts and Achievements of Companies and Universities |
| 3D Tissue Culture: Growing Significance in Cancer Research |
| Cells Grown in 3D Change Cell Proliferation and Morphology |
| Cells Grown in 3D Demonstrate a More Pragmatic Drug Response |
| Cells Grown in 3D Express Phenotypic Heterogeneity |
| Cells Grown in 3D Alter Cell Behavior and Gene Expression |
| Cells Grown in 3D Replicate the Tumor Microenvironment |
| Other Advantages of 3D Tissue Culture Models |
| New Dimension of Cell Culture: The Rise of Spheroid Culture Systems |
| Challenges |
| Progress in Scaffolds and Hydrogels Aids Creation of Organoids and Spheroids |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for 3D Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for 3D Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| World 10-Year Perspective for 3D Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2017, 2020 & 2027 |
| World Current & Future Analysis for Scaffold-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Scaffold-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| World 10-Year Perspective for Scaffold-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027 |
| World Current & Future Analysis for Scaffold-free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Scaffold-free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| World 10-Year Perspective for Scaffold-free by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027 |
| World Current & Future Analysis for Microfluidics-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Microfluidics-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| World 10-Year Perspective for Microfluidics-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027 |
| World Current & Future Analysis for Magnetic & Bioprinted by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Magnetic & Bioprinted by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| World 10-Year Perspective for Magnetic & Bioprinted by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027 |
| World Current & Future Analysis for Cancer & Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cancer & Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| World 10-Year Perspective for Cancer & Stem Cell Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027 |
| World Current & Future Analysis for Drug Discovery & Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Drug Discovery & Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| World 10-Year Perspective for Drug Discovery & Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027 |
| World Current & Future Analysis for Tissue Engineering & Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Tissue Engineering & Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| World 10-Year Perspective for Tissue Engineering & Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| USA 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027 |
| USA Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| USA 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| Canada 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027 |
| Canada Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| Canada 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| Japan 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027 |
| Japan Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| Japan 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| China 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027 |
| China Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| China 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for 3D Cell Culture by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for 3D Cell Culture by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| Europe 10-Year Perspective for 3D Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2017, 2020 & 2027 |
| Europe Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| Europe 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027 |
| Europe Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| Europe 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| France 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027 |
| France Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| France 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| Germany 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027 |
| Germany Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| Germany 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| Italy 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027 |
| Italy Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| Italy 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| UK 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027 |
| UK Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| UK 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| Rest of Europe 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| Rest of Europe 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| Asia-Pacific 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| Asia-Pacific 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| Rest of World 10-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Sales for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2020 & 2027 |
| Rest of World Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2017 through 2019 and % CAGR |
| Rest of World 10-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Sales for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 38 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com